Unique Ingredient Identifier 7FLD91C86K is listed as a ingredient substance
RN | 6381-92-6 |
NCIT | C61741 |
RXCUI | 1310470 |
MF | C10H12N2O8.2Na.2H.2H2O |
INCHI KEY | OVBJJZOQPCKUOR-UHFFFAOYSA-L |
SMILES | [H+].[H+].O.O.[Na+].[Na+].[O-]C(=O)CN(CCN(CC([O-])=O)CC([O-])=O)CC([O-])=O |
UNII 7FLD91C86K EDETATE DISODIUM is commonly included in medications in the following forms.
Route | Dosage Form | Potency |
---|---|---|
AN,INFILTRATION | INJECTION | 0.011 % |
AN,INFILTRATION | SOLUTION, INJECTION | NA |
AURICULAR (OTIC) | SOLUTION | 0.1 % |
AURICULAR (OTIC) | SUSPENSION | NA |
CAUDAL BLOCK | INJECTION | NA |
EPIDURAL | INJECTION | 0.011 % |
IM - IV | INJECTABLE | 0.05 % |
IM - IV | INJECTION | 0.5 MG/1ML |
IM - IV | INJECTION | 0.05 % |
IM - IV | LIQUID, WATER, STERILE, FOR INJECTION | 0.01 % |
IM - IV | SOLUTION, INJECTION | 0.05 % |
IM - IV - SC | INJECTION | 0.2 % |
IM - SC | INJECTION | 0.2 % |
INHALATION | SOLUTION | 0.1 mg/3mL |
INHALATION | SOLUTION | 0.05 %W/V |
INHALATION | SOLUTION, FOR INHALATION | 0.005 % |
INHALATION | SUSPENSION | 0.19 mg/2mL |
INHALATION | SUSPENSION, FOR INHALATION | 0.01 % |
INTRA-ARTERIAL | INJECTION | NA |
INTRA-ARTICULAR | INJECTABLE | 0.01 % |
INTRA-ARTICULAR | INJECTION | 0.05 % |
INTRA-ARTICULAR | INJECTION, SUSTAINED ACTION | NA |
INTRABURSAL | INJECTION | 0.01 % |
INTRACARDIAC | INJECTION | 0.2 mg/1mL |
INTRACARDIAC | INJECTION | NA |
INTRACAVITARY | INJECTION | NA |
INTRADERMAL | INJECTION | NA |
INTRADERMAL | INJECTION, SUSTAINED ACTION | NA |
INTRADISCAL | POWDER, FOR INJECTION SOLUTION | NA |
INTRALESIONAL | INJECTABLE | 0.01 % |
INTRALESIONAL | INJECTION | 0.05 % |
INTRALESIONAL | INJECTION, SUSTAINED ACTION | NA |
INTRAMUSCULAR | INJECTABLE | 0.01 %W/V |
INTRAMUSCULAR | INJECTION | 10 %W/V |
INTRAMUSCULAR | INJECTION | 0.2 mg/1mL |
INTRAMUSCULAR | INJECTION, SOLUTION | 0.02 % |
INTRAMUSCULAR | INJECTION, SUSTAINED ACTION | NA |
INTRAMUSCULAR | SOLUTION, INJECTION | 0.1 %W/V |
INTRASYNOVIAL | INJECTION | NA |
INTRASYNOVIAL | INJECTION, SUSTAINED ACTION | NA |
INTRAUTERINE | SOLUTION | NA |
INTRAVASCULAR | INJECTION | 0.04 % |
INTRAVENOUS | EMULSION, INJECTION | 0.005 % |
INTRAVENOUS | INFUSION | 0.01 % |
INTRAVENOUS | INJECTABLE | 1.1 mg/mL |
INTRAVENOUS | INJECTABLE | 0.01 % |
INTRAVENOUS | INJECTION | 10 % |
INTRAVENOUS | INJECTION | 0.5 MG/1ML |
INTRAVENOUS | INJECTION, SOLUTION | 0.25 MG/1ML |
INTRAVENOUS | LIQUID, WATER, STERILE, FOR INJECTION | 0.5 MG/1ML |
INTRAVENOUS | LIQUID, WATER, STERILE, FOR INJECTION | 0.01 % |
INTRAVENOUS | POWDER, FOR INJECTION SOLUTION | 0.32 MG/1ML |
INTRAVENOUS | POWDER, FOR INJECTION SOLUTION | 0.1 % |
INTRAVENOUS | POWDER, FOR INJECTION SOLUTION, LYOPHILIZED | 1.88 % |
INTRAVENOUS | POWDER, FOR INJECTION SOLUTION, LYOPHILIZED | 0.5 MG/ML |
INTRAVENOUS | SOLUTION | 0.05 % |
INTRAVENOUS | SOLUTION, INJECTION | 0.11 % |
IONTOPHORESIS | PATCH, CONTROLLED RELEASE | 0.1 MG |
IV - SC | SOLUTION, INJECTION | 0.02 % |
IV(INFUSION) | EMULSION, INJECTION | 0.05 % |
IV(INFUSION) | INJECTABLE | 0.02 % |
IV(INFUSION) | INJECTION | 1 % |
IV(INFUSION) | POWDER, FOR INJECTION SOLUTION, LYOPHILIZED | 1.88 % |
IV(INFUSION) | POWDER, FOR INJECTION SUSPENSION, LYOPHILIZED | 0.04 % |
IV(INFUSION) | SOLUTION, INJECTION | 0.04 % |
NASAL | SOLUTION | 0.1 % |
NASAL | SOLUTION, SPRAY | 0.05 % |
NASAL | SOLUTION, SPRAY, METERED, PUMP | 0.007 % |
NASAL | SPRAY | 106 UG/SPRAY |
NASAL | SPRAY | 0.1 % |
NASAL | SPRAY, METERED | 68.5 MCG/SPRAY |
NASAL | SPRAY, METERED | 0.5 % |
NERVE BLOCK | INJECTION | 0.011 % |
NERVE BLOCK | SOLUTION, INJECTION | NA |
OPHTHALMIC | DROPS | 0.05 % |
OPHTHALMIC | EMULSION | 0.3 %W/V |
OPHTHALMIC | GEL | 0.055 % |
OPHTHALMIC | SOLUTION | 1.27 MG/1ML |
OPHTHALMIC | SOLUTION | 0.5 % |
OPHTHALMIC | SOLUTION, DROPS | 0.15 mg/1mL |
OPHTHALMIC | SOLUTION, DROPS | 0.1 % |
OPHTHALMIC | SOLUTION, DROPS | 0.01 %W/V |
OPHTHALMIC | SOLUTION/ DROPS | 0.1 MG/1ML |
OPHTHALMIC | SOLUTION/DROPS | 0.015 % |
OPHTHALMIC | SUSPENSION | 0.13 % |
OPHTHALMIC | SUSPENSION, DROPS | 0.1 % |
ORAL | CAPSULE | 1 MG |
ORAL | CAPSULE (IMMED./COMP. RELEASE) | 1 MG |
ORAL | CAPSULE, SOFT GELATIN | 1 MG |
ORAL | CONCENTRATE | 3 MG/1ML |
ORAL | EMULSION | NA |
ORAL | LIQUID | 0.5 MG/1ML |
ORAL | POWDER, FOR SOLUTION | NA |
ORAL | POWDER, FOR SUSPENSION | 3 MG/5ML |
ORAL | SOLUTION | 210 MG/160ML |
ORAL | SOLUTION | 5.53 MG/5ML |
ORAL | SOLUTION | 2.5 mg/5 mL |
ORAL | SOLUTION, ELIXIR | 0.005 % |
ORAL | SOLUTION, FOR INHALATION | 0.055 MG/.5ML |
ORAL | SOLUTION/DROPS | 0.1 %W/V |
ORAL | SUSPENSION | 7.5 MG/5ML |
ORAL | SUSPENSION, DROPS | 1 MG/2.5ML |
ORAL | SUSPENSION, EXTENDED RELEASE | 10 MG/5ML |
ORAL | SUSPENSION, FOR INHALATION | 0.2 MG/2ML |
ORAL | SUSPENSION, SYRUP, SUSTAINED ACTION | 0.01 % |
ORAL | SYRUP | 25 MG/5ML |
ORAL | TABLET | 4 MG |
ORAL | TABLET | 0.2 ug |
ORAL | TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE | 0.25 MG |
ORAL | TABLET, COATED | 0.21 MG |
ORAL | TABLET, DELAYED ACTION | 100 MG |
ORAL | TABLET, DELAYED ACTION, ENTERIC COATED | 100 MG |
ORAL | TABLET, EFFERVESCENT, FOR SOLUTION | 0.9 MG |
ORAL | TABLET, EXTENDED RELEASE | 5 MG |
ORAL | TABLET, FILM COATED | 4 MG |
ORAL | TABLET, ORALLY DISINTEGRATING | 3 MG |
OTIC | SUSPENSION | 0.01 % |
RECTAL | EMULSION, AEROSOL FOAM | 0.085 % |
RECTAL | ENEMA | 0.1 % |
RECTAL | SOLUTION | 0.04 % |
RESPIRATORY (INHALATION) | INHALANT | 0.011 % |
RESPIRATORY (INHALATION) | SOLUTION | 0.05 % |
RESPIRATORY (INHALATION) | SOLUTION, FOR INHALATION | 0.03 % |
RESPIRATORY (INHALATION) | SPRAY | 0.05 % |
RESPIRATORY (INHALATION) | SUSPENSION, FOR INHALATION | 0.02 % |
SOFT TISSUE | INJECTION | 0.05 % |
SUBCUTANEOUS | INJECTABLE | 0.1 % |
SUBCUTANEOUS | INJECTION | 0.2 % |
SUBCUTANEOUS | INJECTION | 0.2 mg/1mL |
SUBCUTANEOUS | INJECTION, SOLUTION | 0.02 % |
SUBCUTANEOUS | SOLUTION, INJECTION | 0.11 % |
TOPICAL | CREAM | 0.05 %W/W |
TOPICAL | CREAM, AUGMENTED | 0.1 %W/W |
TOPICAL | CREAM, EMULSION, SUSTAINED RELEASE | 0.05 %W/W |
TOPICAL | DROPS | 0.05 %W/V |
TOPICAL | EMULSION | 0.11 %W/W |
TOPICAL | EMULSION, AEROSOL FOAM | 0.05 %W/W |
TOPICAL | EMULSION, CREAM | 0.1 %W/W |
TOPICAL | FILM, CONTROLLED RELEASE | 14 MG |
TOPICAL | GEL | 0.17 %W/W |
TOPICAL | LOTION | 0.12 %W/V |
TOPICAL | LOTION | 0.05 %W/W |
TOPICAL | OINTMENT | 0.007 %W/W |
TOPICAL | OPHTHALMIC SUSPENSION DOSAGE FORM | 0.06 %W/V |
TOPICAL | PATCH | 7 MG |
TOPICAL | PATCH, CONTROLLED RELEASE | NA |
TOPICAL | POWDER, FOR SOLUTION | NA |
TOPICAL | SOLUTION | 1.27 MG/1ML |
TOPICAL | SOLUTION | 0.1 %W/W |
TOPICAL | SOLUTION, DROPS | 0.05 %W/V |
TOPICAL | SOLUTION/DROPS | 0.01 %W/V |
TOPICAL | SUSPENSION | NA |
TOPICAL | SUSPENSION, DROPS | 0.1 %W/W |
TRANSDERMAL | GEL | 0.06 % |
URETERAL | SOLUTION | NA |
URETHRAL | SOLUTION | NA |
VAGINAL | CREAM | 0.05 %W/W |
VAGINAL | CREAM, EMULSION, SUSTAINED RELEASE | 0.05 % |
VAGINAL | EMULSION, CREAM | 0.05 % |
VAGINAL | GEL | 0.05 % |